Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01427296 · ClinicalTrials.gov registry record · Phase 4
Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing
A Phase 4 study of Colon Cleansing, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 4
- Development phase
- 2,154
- Enrollment target
- 18
- Study locations
NCT01427296: Completed Phase 4 study of Colon Cleansing, sponsored by Bausch Health Americas.
NCT01427296 is a Phase 4 study of Colon Cleansing that has completed, run by Bausch Health Americas. The registered enrollment target is 2,154 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (316% higher). The trial reports 18 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01427296, a Phase 4 study of Colon Cleansing, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2,154 participants
- Enrollment target
- 18
- Study locations
Study Summary
The purpose of this study is to compare the safety and efficacy of OsmoPrep tablets versus HalfLytely and Bisacodyl Tablet Bowel Prep Kit in subjects who are undergoing colonoscopy.
Conditions Studied
Interventions
- DRUG Polyethylene glycol
- DRUG Oral sodium phosphate solution
Study Locations (18)
North Carolina
- - Fayetteville
- - High Point
- - Raleigh
Georgia
- - Macon
- - Suwanee
New York
- - Great Neck
- - New York
Ohio
- - Cincinnati
- - Mentor
California
- - San Carlos
Connecticut
- - Bristol
Maryland
- - Hagerstown
Michigan
- - Wyoming
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,154 participants |
| Start Date | 2011-09-16 |
| Est. Completion | 2014-12-09 |
| Phase | Phase 4 |
What the finished NCT01427296 record still lists
NCT01427296 is an interventional study that assigns participants to a tested intervention. Its 2,154 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (316% higher).
The record links to 1 condition, with Colon Cleansing appearing as the primary indexed condition, and to 2 interventions - of which Polyethylene glycol is the first listed.
NCT01427296 lists 18 locations in 13 states (North Carolina, Georgia, New York).
Frequently Asked Questions
What is clinical trial NCT01427296 about?
NCT01427296 is a clinical study titled "Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing". The purpose of this study is to compare the safety and efficacy of OsmoPrep tablets versus HalfLytely and Bisacodyl Tablet Bowel Prep Kit in subjects who are undergoing colonoscopy.
What is the current status of trial NCT01427296?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2,154 participants. The study started on 2011-09-16. Estimated completion is 2014-12-09.
What conditions does trial NCT01427296 study?
This clinical trial studies the following conditions: Colon Cleansing.
What interventions are being tested in trial NCT01427296?
The interventions under investigation include: Polyethylene glycol (DRUG), Oral sodium phosphate solution (DRUG).
Who is sponsoring clinical trial NCT01427296?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01427296 being conducted?
This trial has 18 study locations across California, Connecticut, Georgia, Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colon Cleansing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01427296's enrollment target sits among peer trials
2,154 33rd of 2000 higher than 1,968 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06783335 · 2,150 participants
Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure
- NCT05742178 · 2,160 participants · NA
NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation
- NCT05805709 · 2,145 participants · NA
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
- NCT06598475 · 2,142 participants · NA
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI